Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders

Autor: BIZOT, Flavien, Vulin, Adeline, Goyenvalle, Aurélie
Přispěvatelé: Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), SQY Therapeutics, Laboratoire International Associé 'Biothérapies Appliquées aux Handicaps Neuromusculaires' (LIA BAHN), Centre Scientifique de Monaco, BIZOT, FLAVIEN
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Drugs
Drugs, Springer Verlag, In press, ⟨10.1007/s40265-020-01363-3⟩
ISSN: 0012-6667
DOI: 10.1007/s40265-020-01363-3⟩
Popis: International audience; Neuromuscular disorders include a wide range of diseases affecting the peripheral nervous system, which are primarily characterized by progressive muscle weakness and wasting. While there were no effective therapies until recently, several therapeutic approaches have advanced to clinical trials in the past few years. Among these, the antisense technology aiming at modifying RNA processing and function has remarkably progressed and a few antisense oligonucleotides (ASOs) have now been approved. Despite these recent clinical successes, several ASOs have also failed and clinical programs have been suspended, in most cases when the route of administration was systemic, highlighting the existing challenges notably with respect to effective ASO delivery. In this review we summarize the recent advances and current status of antisense based-therapies for neuromuscular disorders, using successful as well as unsuccessful examples to highlight the variability of outcomes depending on the target tissue and route of administration. We describe the different ASO-mediated therapeutic approaches, including splice-switching applications, steric-blocking strategies and targeted gene knock-down mediated by ribonuclease H recruitment. In this overview, we discuss the merits and challenges of the current ASO technology, and discuss the future of ASO development.
Databáze: OpenAIRE
Externí odkaz: